Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Where those buys yesterday?
I suppose demand is there at the right price.
hopefully its the same with finance - the demand is there, but the price?.....well that is going to be the sticking point. and will be extremely interesting....
otherwise...this is the end.....
Its not listed on AIM roger
So many tiny buys today. like a school of tiny fishes.
the kind of people who like to spend 80p on a share, they like IQAI.
why do they like IQAI? who are they? are they even people ? Maybe they are some kind of computer trade from an Austin Powers type figure in a major bank or fund with complex algorithms and billions - well 80p - at their disposal, setting their sights on little old IQAI.
INL were one of 2 strategic Asian investors. Its easy to say rats and sinking ship. I suppose its more likely its something more complex - as CLNs and debt is passed about and everything is getting restructured in complex deal that will obviously be of great benefit to shareholders.
While its easy to laugh at the Pepsi connection the company is pivoting more to the US so while m007j would probably fall off his chair if it happens I wouldn't rule out a new American partner. Granted the company is ever so fragile looking but the amounts necessary to prop it up are just not very big.
Is that closing in on 7p to buy?
Thats still cheap IMO
Should be 10p+
We now know that UKHSA takes SNG001 seriously - c'mon that means large pharma and grant giving bodies take Synairgen seriously - it may not mean anything commercially, at the moment. But it may well increase the probability of Synairgen putting together some kind of deal - a mixture of grant funding and a few quid from a JV partner....lets see.
Good news. it means that while some here - in their various guises - do not take the company seriously. it shows us that others - UK Govt scientists etc do take this company seriously. should be 10p+. even though this is not commercial news .
Thanks Buddsodd
Yes its just a small percentage of my pf.
Once they secure funding the buys will flood in.
If they don't secure funding then that's a major drag.
Such...is....life.
Thanks for that
Yes after SND and the Redx I was just thinking 'damn this whole private thing'. it's a whole new area of risk to consider. and very hard if - like me - you are not super literate about how these situations evolve. I guess because JM does not inspire too much trust and because of the (failed?) share buyback project - I just thought they must be a bit frustrated. and they won't like it if the sp is lower than NAV - then we get a great deal - I just don't think this system is designed for small investors to get a great deal. but...hey...please keep sharing information. it helps.
1b/2a
any idea of the costs involved here? So no 1b acc to the last RNS - possibly go straight to 2a - and that is not a definite - but is that OK for safety and procedure - they are not cutting corners to save £? I hope not. Anyway how much will it cost? Any guesses...I wasn't going to post here for a while, sorry to be a downer when some of u might be feeling a bit more chipper but today's RNS from Faron just made me think of SAR...
From FARN's RNS today....
"-To complete the enrolment of the phase 2 of the BEXMAB study with interim and final readouts and to obtain regulatory feedback from the FDA between now and Q1/2025, the Company expects to need an additional EUR 27 million in total (accounting for the raised EUR 8 million in early March and this Placing)."
Hopefully SAR need a bit less than that. For sure might be a JV etc.. And yes the JV might cover of all of it or part of it but...one needs to be aware, I guess.
Bermuda
Thanks. Yes I wondered if there was any upside/value to holding a delisted stock. Most holders run a mile and consider the shares worthless. I suppose you have to hold them until the private company engineers a buyout or something similar - which could be a years long wait. And I don't suppose you have much say in the whole ongoing process if more funds are needed and other backers come in....its not really my game. AIM is for small investors. Taking chunks of private companies is more for venture capital type investors and funds- I would have thought.
Bermuda
So you will hold even when the company is private? That is very interesting. Because this is not the only company that is going private - not just pharmas but many high value/high potential companies on AIM are delisting at the moment. Most investors don't want to hold a stock when its going private - see sp above. I don't suppose you are adding to your holding then?
Hmm. did I write 3p?
OK. Thats over-egging the pudding.
I just get a bit hot under the collar sometimes. The ramping and hype on this board has been proven to be completely out of order - facts have proven them wrong by a factor of 90 per ent losses. They are either spectacularly ignorant or worse and have been working in concert.
Its highly probable this will multiply many times from....
you can't say that for certain. I think when people are nursing 90 per cent losses its time to look carefully at people who say things like this and thing long and hard about their degree of enthusiasm. which is great, good for them. but maybe balance it with an understanding that Sareum may have to seek funding for 1b (that's my bugbear and I don't claim to be correct) and that the 1b trial could easily yield results that are either hopeless or just not quite good enough for a commercial product. so...
its just as probably that from here a fundraise takes the share price down to 3p and that a less than successful 1b type trial takes the share price down 0.2
i'm sure you are all aware of the risks - but you can't be - otherwise people wouldn't have lost 90%? I can only assume that risk management wasn't taken seriously. please take risk management seriously. and have a good weekend.
There's no 1b.
the original RFO funding was for 1a and 1b because if there's no 1b there's no serious data. and if there is no serious data of trialling the drug on actual, sick people there is less chance of getting JV or license deal. but granted its only how i see it.
so now we have no 1b. and no sp. and warrants. not great. and I feel bad for anyone who is seriously down - don't believe the mad, in-humane rampers - guess what I'm not down because I never believed them.
Anyway things may well turn out OK. There's years of research in this company. 737 shows they can break through. So lets see what happens next.
I might be wrong but the bigger traders I know were telling me hold off on buying DGI because a fundraise is due to pay for manufacturing/factory etc. Looks like the company has got there with no raise. Lets see what happens next. Glad I ignored my trader mates - I just figured this was one to buy as its going to be a huge mcap company by xmas....huge.
Trek - they won't complain.
Quite a few of the holders think they got a good deal. Same mistake they made last time.
I'm glad the company is still going but I thought they need 1b data to get a JV or a deal - that's when they trial the drug on real life sick people. And that still a way away. Still good the company is going to keep going and there's plenty of material for the rampers to play with. As always one can buy - just carefully.